Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Motapizone (NAT 05-239) is a selective PDE3 inhibitor that not only moderately reduces cytokine release in lipopolysaccharide (LPS)-stimulated alveolar macrophages but also suppresses human platelet aggregation by elevating intracellular cAMP levels [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Motapizone (NAT 05-239) is a selective PDE3 inhibitor that not only moderately reduces cytokine release in lipopolysaccharide (LPS)-stimulated alveolar macrophages but also suppresses human platelet aggregation by elevating intracellular cAMP levels [1] [2]. |
Molecular Weight | 260.31 |
Formula | C12H12N4OS |
CAS No. | 90697-57-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Motapizone 90697-57-7 inhibitor inhibit